|
|
|
Symbicort
|
Profiles in asthma control
Trail Blazer. Noticing a difference.
Budesonide/formoterol is a combination formulation containing budesonide and formoterol used in the management of asthma and chronic obstructive pulmonary disease (COPD) in the EU. It is marketed by AstraZeneca under the trade name Symbicort. Symbicort in the United States is a metered-dose inhaler[citation needed] while in the EU, Australia, Canada, Israel, and elswhere Symbicort is available as a dry powder inhaler.
Symbicort contains two active ingredients which are delivered via a single inhaler:
|
|
| Rate this file (No vote yet) |
|
|
|
|
|
|
